Prospective, randomized, phase II-b trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage

Trial Profile

Prospective, randomized, phase II-b trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage

Completed
Phase of Trial: Phase II

Latest Information Update: 31 May 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Embolism and thrombosis; Subarachnoid haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 May 2017 Last checked against ISRCTN: Current Controlled Trials record.
    • 05 Sep 2012 New source identified and integrated: ISRCTN record.
    • 05 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ISRCTN record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top